| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP Finance CFO | SVP Finance &CFO
2 companies
Landry Robert E is an EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $15.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 107 | $400.05 | $42,805.63 | - | |
| Sep 6, 2017 | REGN Regeneron Pharmaceuticals, Inc. | SVP Finance &CFO | Sale+OE | 663 | $498.60 | $330,573.80 | -1.3% | |
| Aug 31, 2017 | REGN Regeneron Pharmaceuticals, Inc. | SVP Finance &CFO | Sale+OE | 427 | $493.43 | $210,692.63 | -1.4% | |
| Aug 23, 2017 | REGN Regeneron Pharmaceuticals, Inc. | SVP Finance &CFO | Sale+OE | 468 | $476.45 | $222,980.80 | -1.6% | |
| Aug 8, 2017 | REGN Regeneron Pharmaceuticals, Inc. | SVP Finance &CFO | Sale+OE | 526 | $472.19 | $248,371.82 | -1.8% |